HIT Consultant June 21, 2024
What You Should Know:
– The pharmaceutical and life sciences (PLS) sector is experiencing a resurgence in dealmaking activity, with a 20% increase in deal volume over the past year reported, according to PwC’s latest US Midyear Deals 2024 Outlook for Pharmaceutical and Life Sciences.
– M&A activity in the PLS sector is expected to remain strong throughout 2024 and potentially into 2025. Clarity on factors like US election outcomes and Federal Reserve interest rate decisions could further bolster investor confidence and fuel even more deals.
Key Drivers of Increased M&A Activity:
- Innovation Focus: Companies are strategically acquiring assets in high-innovation areas like gene therapy and novel drug treatments to address patent expirations later this decade.
- Strong...
Today's Sponsors
Today's Sponsor